Literature DB >> 36251229

The Role of Gut Microbiota and Trimethylamine N-oxide in Cardiovascular Diseases.

Yan Huang1,2, Han Zhang1, Xin Fan1, Junpeng Wang2, Yuzhen Yin1, Yu Zhang1, Kuangyu Shi3,4, Fei Yu5,6.   

Abstract

Changes in the intestinal flora and its metabolites have been associated with cardiovascular disease (CVD). Short-chain fatty acids, bile acids, and especially trimethylamine N-oxide (TMAO), an endothelial toxic factor produced by gut microbiota from phosphatidylcholine in meat, have been identified to be closely related to endothelial cell dysfunction as well as tightly affiliated with CVD, the two main types being coronary artery disease (CAD) and coronary microvascular disease (CMVD). We discuss how changes in the gut flora and the metabolite TMAO contribute to the development of CAD and CMVD. The above insight might serve as a stepping stone for novel CAD and CMVD diagnostics and therapies centered on microbiota.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Coronary artery disease; Coronary microvascular diseases; Gut microbiota; Trimethylamine N-oxide

Year:  2022        PMID: 36251229     DOI: 10.1007/s12265-022-10330-0

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   3.216


  29 in total

Review 1.  Gut Microbiota in Cardiovascular Health and Disease.

Authors:  W H Wilson Tang; Takeshi Kitai; Stanley L Hazen
Journal:  Circ Res       Date:  2017-03-31       Impact factor: 17.367

Review 2.  Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-of-the-Art Review.

Authors:  Viviany R Taqueti; Marcelo F Di Carli
Journal:  J Am Coll Cardiol       Date:  2018-11-27       Impact factor: 24.094

Review 3.  Expanding role of gut microbiota in lipid metabolism.

Authors:  Anatole Ghazalpour; Ivana Cespedes; Brian J Bennett; Hooman Allayee
Journal:  Curr Opin Lipidol       Date:  2016-04       Impact factor: 4.776

4.  Human oral, gut, and plaque microbiota in patients with atherosclerosis.

Authors:  Omry Koren; Aymé Spor; Jenny Felin; Frida Fåk; Jesse Stombaugh; Valentina Tremaroli; Carl Johan Behre; Rob Knight; Björn Fagerberg; Ruth E Ley; Fredrik Bäckhed
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

Review 5.  Pathophysiology of coronary artery disease.

Authors:  Peter Libby; Pierre Theroux
Journal:  Circulation       Date:  2005-06-28       Impact factor: 29.690

Review 6.  PCSK9 Promotes Cardiovascular Diseases: Recent Evidence about Its Association with Platelet Activation-Induced Myocardial Infarction.

Authors:  Meidi Utami Puteri; Nuriza Ulul Azmi; Mitsuyasu Kato; Fadlina Chany Saputri
Journal:  Life (Basel)       Date:  2022-01-27

7.  Gut bacterial phospholipase Ds support disease-associated metabolism by generating choline.

Authors:  Carina L Chittim; Ana Martínez Del Campo; Emily P Balskus
Journal:  Nat Microbiol       Date:  2018-11-19       Impact factor: 17.745

Review 8.  Gut microbiota and cardiovascular disease: opportunities and challenges.

Authors:  Negin Kazemian; Morteza Mahmoudi; Frank Halperin; Joseph C Wu; Sepideh Pakpour
Journal:  Microbiome       Date:  2020-03-14       Impact factor: 14.650

9.  Gut microbiota derived trimethylamine N-oxide (TMAO) detection through molecularly imprinted polymer based sensor.

Authors:  G B V S Lakshmi; Amit K Yadav; Neha Mehlawat; Rekha Jalandra; Pratima R Solanki; Anil Kumar
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

Review 10.  Toll-Like Receptors Regulate the Development and Progression of Renal Diseases.

Authors:  Minghui Liu; Ke Zen
Journal:  Kidney Dis (Basel)       Date:  2020-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.